Skip to content
← All treatment topics

TREATMENT READING

Childhood Ovarian Cancer

Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

26 sections
  1. Treatment of Childhood Epithelial Ovarian Neoplasia
  2. Treatment of childhood sex cord–stromal tumors
  3. Treatment of childhood juvenile granulosa cell tumors
  4. Surgery
  5. Chemotherapy
  6. Treatment and outcome of childhood Sertoli-Leydig cell tumors
  7. Surgery
  8. Chemotherapy
  9. Treatment of Childhood Small Cell Carcinoma of the Ovary, Hypercalcemia-Type
  10. Aggressive multimodality therapy
  11. Tazemetostat
  12. Treatment Options Under Clinical Evaluation for Childhood Ovarian Cancer
  13. Special Considerations for the Treatment of Children With Cancer
  14. Types of treatment for childhood ovarian cancer
  15. Who treats children with ovarian cancer?
  16. Surgery
  17. Chemotherapy
  18. Stem cell transplant
  19. Targeted therapy
  20. Clinical trials
  21. Treatment of benign childhood ovarian tumors
  22. Treatment of childhood ovarian epithelial cancer
  23. Treatment of childhood ovarian stromal tumors
  24. Treatment of childhood small cell carcinoma of the ovary
  25. Treatment of recurrent ovarian cancer
  26. Side effects and late effects of treatment

Health professional · Childhood Epithelial Ovarian Neoplasia

Treatment of Childhood Epithelial Ovarian Neoplasia

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Treatment options for nonmalignant childhood epithelial ovarian neoplasia include the following:

Surgery alone.

Treatment of epithelial ovarian neoplasia is based on stage and histology. Most pediatric and adolescent patients have stage I disease. In the TREP study,[3] of the eight patients with benign tumors, seven patients had stage I disease, and one patient had stage III disease. Of the eight patients with borderline tumors, three patients had stage I disease, and five patients had stage III disease (based on washings and omental implants). All 16 patients were treated with surgery alone. At the time of the report, 15 patients were alive without disease; the one death was not from ovarian cancer.

Sources: 3

Treatment options for childhood malignant ovarian epithelial cancer include the following:

Surgery.

Chemotherapy.

Treatment of malignant ovarian epithelial cancer is stage-related and follows adult protocols, which may include surgery and chemotherapy. For more information, see Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment.

Sources: Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment

This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.

Health professional · Childhood Sex Cord–Stromal Tumors / General Information About Sex Cord–Stromal Tumors

Treatment of childhood sex cord–stromal tumors

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Treatment options for childhood sex cord–stromal tumors include the following:

Surgery.

Chemotherapy.

A French registry identified 38 girls younger than 18 years with ovarian sex cord–stromal tumors.[2]

Sources: 2

Complete surgical resection was achieved in 23 of 38 girls who did not receive adjuvant treatment.

Two patients who had a complete surgical resection had recurrent disease. One patient's tumor responded to chemotherapy, and the other patient died.

Fifteen girls had tumor rupture and/or ascites. Eleven of the 15 patients received chemotherapy and did not have a disease recurrence. Of the four patients who did not receive chemotherapy, all had a recurrence and two died.

Health professional · Childhood Sex Cord–Stromal Tumors / Childhood Juvenile Granulosa Cell Tumors

Treatment of childhood juvenile granulosa cell tumors

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Treatment options for childhood juvenile granulosa cell tumors include the following:

Surgery.

Sources: Surgery

Chemotherapy.

Sources: Chemotherapy

Health professional · Childhood Sex Cord–Stromal Tumors / Childhood Juvenile Granulosa Cell Tumors / Treatment of childhood juvenile granulosa cell tumors

Surgery

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

As many as 90% of children with juvenile granulosa cell tumors will have low-stage disease (stage I) by FIGO criteria. These patients are usually curable with unilateral salpingo-oophorectomy alone. In one series, 15 of 17 patients underwent fertility-sparing surgery, and only two patients received adjuvant chemotherapy. No recurrences were reported.[19]

Sources: 19

Health professional · Childhood Sex Cord–Stromal Tumors / Childhood Juvenile Granulosa Cell Tumors / Treatment of childhood juvenile granulosa cell tumors

Chemotherapy

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Patients with spontaneous tumor rupture or malignant ascites (FIGO stage IC2, IC3), advanced disease (FIGO stages II–IV), or tumors with high mitotic activity have a poorer prognosis and require chemotherapy.[2,4,13] Cisplatin-based chemotherapy regimens have been used with some success in both the adjuvant and recurrent disease settings.[4,11,20-22]

Sources: 2 · 4 · 13 · 4 · 11 · 20 · 22

Health professional · Childhood Sex Cord–Stromal Tumors / Childhood Sertoli-Leydig Cell Tumors

Treatment and outcome of childhood Sertoli-Leydig cell tumors

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Treatment options for childhood Sertoli-Leydig cell tumors include the following:

Surgery.

Sources: Surgery

Chemotherapy.

Sources: Chemotherapy

Health professional · Childhood Sex Cord–Stromal Tumors / Childhood Sertoli-Leydig Cell Tumors / Treatment and outcome of childhood Sertoli-Leydig cell tumors

Surgery

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Surgery is the primary treatment for Sertoli-Leydig cell tumors and is the only treatment for low-stage disease (FIGO stage IA). The event-free survival rate for these patients is approximately 100%.[2][Level of evidence C1] However, up to 10% of patients may develop metachronous contralateral tumors, particularly in the context of underlying DICER1 germline pathogenic variants.[28]

Sources: 2 · Level of evidence C1 · 28

Health professional · Childhood Sex Cord–Stromal Tumors / Childhood Sertoli-Leydig Cell Tumors / Treatment and outcome of childhood Sertoli-Leydig cell tumors

Chemotherapy

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Patients with Sertoli-Leydig cell tumors with abdominal spillage during surgery, spontaneous tumor rupture, or metastatic disease (FIGO stages IC, II, III, and IV) are treated with cisplatin-based combination chemotherapy, although the impact of chemotherapy has not been studied in clinical trials in children.[2,10]

Sources: 2 · 10

One study reported on 40 women (average age, 28 years) with FIGO stage I or IC Sertoli-Leydig cell tumors of the ovary.[29][Level of evidence C1]

Sources: 29 · Level of evidence C1

Of 34 patients with intermediate or poor differentiation, 23 patients received postoperative chemotherapy (most regimens included cisplatin). None of these patients experienced disease recurrence.

Of the 11 patients who did not receive postoperative chemotherapy, two had disease recurrence. Both of these patients had tumors that were salvaged with chemotherapy.

Health professional · Childhood Small Cell Carcinoma of the Ovary, Hypercalcemia-Type

Treatment of Childhood Small Cell Carcinoma of the Ovary, Hypercalcemia-Type

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Treatment options for childhood small cell carcinoma of the ovary, hypercalcemia-type, include the following:

Aggressive multimodality therapy.

Sources: Aggressive multimodality therapy

Tazemetostat.

Sources: Tazemetostat

Health professional · Childhood Small Cell Carcinoma of the Ovary, Hypercalcemia-Type / Treatment of Childhood Small Cell Carcinoma of the Ovary, Hypercalcemia-Type

Aggressive multimodality therapy

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Successful treatment has been reported in a few cases using aggressive therapy, including surgery and high-dose chemotherapy with stem cell rescue.[2,7-9][Level of evidence C1]

Sources: 2 · 7 · 9 · Level of evidence C1

Health professional · Childhood Small Cell Carcinoma of the Ovary, Hypercalcemia-Type / Treatment of Childhood Small Cell Carcinoma of the Ovary, Hypercalcemia-Type

Tazemetostat

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Tazemetostat is an EZH2 inhibitor that demonstrates activity against preclinical models of small cell carcinoma of the ovary with SMARCA4 loss.[10]

Sources: 10

Evidence (tazemetostat):

Two patients with small cell carcinoma of the ovary and SMARCA4 loss were enrolled in a phase I trial of tazemetostat.[11]

Sources: 11

Two patients with small cell carcinoma of the ovary and SMARCA4 loss were enrolled in a phase I trial of tazemetostat.[11]

One patient achieved a partial response, and one patient achieved prolonged stable disease.

The most common toxicities associated with tazemetostat were asthenia, anemia, anorexia, muscle spasms, nausea, and vomiting.

Health professional

Treatment Options Under Clinical Evaluation for Childhood Ovarian Cancer

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.

Sources: NCI website · ClinicalTrials.gov website

The following is an example of a national and/or institutional clinical trial that is currently being conducted:

PEPN2121 (NCT05286801) (Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1- or SMARCA4-Deficient Tumors): This trial is evaluating the combination of a PD-L1 targeting antibody (atezolizumab) with a TIGIT targeting antibody (tiragolumab) for patients with SMARCB1- or SMARCA4-deficient tumors. Patients with small cell carcinomas of the ovary, hypercalcemia type, may be eligible for this study.

Sources: PEPN2121 (NCT05286801)

Health professional

Special Considerations for the Treatment of Children With Cancer

Source: Childhood Ovarian Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 3, 2025. Captured 2026-09-09.

Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:

Sources: 1

Primary care physicians.

Pediatric surgeons.

Pathologists.

Pediatric radiation oncologists.

Pediatric medical oncologists and hematologists.

Ophthalmologists.

Rehabilitation specialists.

Pediatric oncology nurses.

Social workers.

Child-life professionals.

Psychologists.

Nutritionists.

For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.

Sources: Supportive and Palliative Care

The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.

Sources: 2 · NCI website

Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.

Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer

Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.

Sources: 6 · Rare Diseases Act of 2002

The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:

Sources: 7 · 8

A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]

Sources: 9

The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.

Sources: 10 · 4

These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.

Information about these tumors may also be found in sources relevant to adults with cancer, such as Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment.

Sources: Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment

For patients

Types of treatment for childhood ovarian cancer

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

For patients · Types of treatment for childhood ovarian cancer

Who treats children with ovarian cancer?

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

A pediatric oncologist, a doctor who specializes in treating children with cancer, oversees treatment for childhood ovarian cancer. The pediatric oncologist works with other health care providers who are experts in treating children with cancer and who specialize in certain areas of medicine. Other specialists may include:

pediatrician

Sources: pediatrician

pediatric surgeon

Sources: pediatric surgeon

gynecologist

Sources: gynecologist

pathologist

Sources: pathologist

pediatric nurse specialist

Sources: pediatric nurse specialist

rehabilitation specialist

Sources: rehabilitation specialist

social worker

Sources: social worker

psychologist

Sources: psychologist

fertility specialist

Sources: fertility specialist

There are different types of treatment for children and adolescents with ovarian tumors. You and your child's cancer care team will work together to decide treatment. Many factors will be considered, such as your child's overall health, whether the tumor is benign or cancerous, and whether the tumor is newly diagnosed or has come back.

Sources: benign · cancerous

Your child's treatment plan will include information about the cancer, the goals of treatment, treatment options, and the possible side effects. It will be helpful to talk with your child's cancer care team before treatment begins about what to expect. For help every step of the way, see our booklet, Children with Cancer: A Guide for Parents.

Sources: Children with Cancer: A Guide for Parents

The types of treatment your child might have include:

For patients · Types of treatment for childhood ovarian cancer

Surgery

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

Surgery is used to remove a tumor in the ovary. Sometimes the ovary and/or fallopian tube are also removed. During surgery to remove the tumor, fluid in the abdomen will be checked for signs of cancer.

Sources: fluid in the abdomen

For patients · Types of treatment for childhood ovarian cancer

Chemotherapy

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

Chemotherapy (also called chemo) uses drugs to stop the growth of cancer cells. Chemotherapy either kills the cancer cells or stops them from dividing.

Chemotherapy may be given in different ways. For ovarian cancer, chemotherapy is injected into a vein. When given this way, the drugs enter the bloodstream and can affect cancer cells throughout the body. Chemotherapy drugs used alone or in combination to treat ovarian cancer in children include:

bleomycin

Sources: bleomycin

carboplatin

Sources: carboplatin

cisplatin

Sources: cisplatin

cyclophosphamide

Sources: cyclophosphamide

etoposide

Sources: etoposide

ifosfamide

Sources: ifosfamide

vinblastine

Sources: vinblastine

Other chemotherapy drugs not listed here may also be used.

Learn more about how chemotherapy works, how it is given, common side effects, and more at Chemotherapy to Treat Cancer.

Sources: Chemotherapy to Treat Cancer

For patients · Types of treatment for childhood ovarian cancer

Stem cell transplant

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

High doses of chemotherapy are given to kill cancer cells. This cancer treatment destroys healthy cells, including blood-forming cells. Stem cell transplant (also called stem cell rescue) is a treatment to replace the blood-forming cells. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient and are frozen and stored. After the patient completes chemotherapy, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body's blood cells.

Sources: infusion

For patients · Types of treatment for childhood ovarian cancer

Targeted therapy

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

Targeted therapy uses drugs or other substances to block the action of specific enzymes, proteins, or other molecules involved in the growth and spread of cancer cells.

Sources: enzymes

Tazemetostat is used to treat ovarian cancer.

Sources: Tazemetostat

Learn more about Targeted Therapy to Treat Cancer.

Sources: Targeted Therapy to Treat Cancer

For patients · Types of treatment for childhood ovarian cancer

Clinical trials

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

For some children, joining a clinical trial may be an option. There are different types of clinical trials for childhood cancer. For example, a treatment trial tests new treatments or new ways of using current treatments. Supportive care and palliative care trials look at ways to improve quality of life, especially for those who have side effects from cancer and its treatment.

You can use the clinical trial search to find NCI-supported cancer clinical trials accepting participants. The search allows you to filter trials based on the type of cancer, your child's age, and where the trials are being done. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.

Sources: clinical trial search · ClinicalTrials.gov

Learn more about clinical trials, including how to find and join one, at Clinical Trials Information for Patients and Caregivers.

Sources: Clinical Trials Information for Patients and Caregivers

For patients · Types of treatment for childhood ovarian cancer

Treatment of benign childhood ovarian tumors

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

Treatment of newly diagnosed benign ovarian tumors in children may include surgery.

For patients · Types of treatment for childhood ovarian cancer

Treatment of childhood ovarian epithelial cancer

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

Treatment of newly diagnosed ovarian epithelial cancer in children may include:

surgery

chemotherapy

For patients · Types of treatment for childhood ovarian cancer

Treatment of childhood ovarian stromal tumors

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

Treatment of newly diagnosed ovarian stromal tumors, including juvenile granulosa cell tumors and Sertoli-Leydig cell tumors, in children may include:

surgery to remove one ovary and one fallopian tube for early cancer

surgery followed by chemotherapy for advanced cancer

Sources: advanced cancer

chemotherapy for cancer that has recurred (come back)

For patients · Types of treatment for childhood ovarian cancer

Treatment of childhood small cell carcinoma of the ovary

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

Treatment of newly diagnosed small cell carcinoma of the ovary in children may include:

surgery followed by chemotherapy and high-dose chemotherapy with stem cell rescue

targeted therapy (tazemetostat)

For patients · Types of treatment for childhood ovarian cancer

Treatment of recurrent ovarian cancer

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

If the cancer comes back after treatment, your child's doctor will talk with you about what to expect and possible next steps. There might be treatment options that may shrink the cancer or control its growth. If there are no treatment options, your child can receive care to control symptoms from cancer so they can be as comfortable as possible.

For patients

Side effects and late effects of treatment

Source: Childhood Ovarian Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 8, 2025. Captured 2026-09-09.

Cancer treatments can cause side effects. Which side effects your child might have depends on the type of treatment they receive, the dose, and how their body reacts. Talk with your child's treatment team about which side effects to look for and ways to manage them.

To learn more about side effects that begin during treatment for cancer, visit Side Effects.

Sources: side effects · Side Effects

Problems from cancer treatment that begin 6 months or later after treatment and continue for months or years are called late effects. Physical problems, such as problems with fertility, are a late effect of treatment.

Sources: fertility

Some late effects may be treated or controlled. It is important to talk with your child's doctors about the possible late effects caused by some treatments. Learn more about Late Effects of Treatment for Childhood Cancer.

Sources: Late Effects of Treatment for Childhood Cancer

Disease and treatment settings

Childhood Ovarian Cancer

Disease and treatment setting

Ovarian Cancer in children and adolescents

recurrent Childhood Ovarian Cancer

Disease and treatment setting

Treatment of recurrent ovarian cancer